Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...
Elevance Health (ELV) Initiated with a Buy at Cantor Fitzgerald
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Elevance Health price target raised to $512 from $501 at Barclays
Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...
Elevance Health Inc (ELV) Q4 2024 Earnings Call Highlights: Strong EPS and Revenue Growth Amid ...
Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...
Benefits Pro19h
Elevance expects commercial health cost trends to stay high
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
marketinference20h
Elevance Health Reports Strong Financial Performance
Elevance Health's quarterly dividend has been increased by 5% to $1.71 per share. The company's president and CEO, Gail K. Boudreaux, expressed the commitment to simplifying the healthcare experience ...
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...